Results 71 to 80 of about 675 (153)

Actualización sobre las bases fisiopatológicas y terapéuticas del vitíligo [PDF]

open access: yes, 2022
El vitíligo es una enfermedad crónica autoinmune caracterizada por la pérdida de melanocitos funcionales y, de manera consecuente, de la pigmentación de la piel.
Galdón Rus, Irene
core  

Revisión bibliográfica: caracterización aspectos clínicos y tratamiento de pacientes con vitíligo [PDF]

open access: yes, 2023
El vitíligo es una enfermedad autoinmune que da como resultado la despigmentación de la piel, generando un importante impacto en el estilo de vida y la autoestima de quienes lo padecen.
de Lourdes, Quevedo Valverde Maria   +7 more
core   +1 more source

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

open access: yes, 2022
The human {\it ether-a-go-go} (hERG) potassium channel (K$_\text{v}11.1$) plays a critical role in mediating cardiac action potential. The blockade of this ion channel can potentially lead fatal disorder and/or long QT syndrome.
Feng, Hongsong, Wei, Guowei
core  

Synthesis and physiochemical characterization of new siderophore-inspired peptide-chelators with 1-hydroxypridine-2-one (1,2-HOPO). [PDF]

open access: yes, 2020
Doctoral Degree. University of KwaZulu-Natal, Durban.Compounds containing hydroxamate moieties (N-hydroxyl amides) in their structure have found a vast range of therapeutic applications such as antibacterial, anti-tumour, anti-immune suppressor, and ...
Alshaer, Danah Mahdi Mohammad.
core  

Chronic Inducible Urticaria: Part II [PDF]

open access: yes, 2017
Physical urticaria (PU) is a subgroup of acquired, chronic inducible urticaria which is associated with a known physical trigger. In PU, the symptoms are induced by exogenous physical triggers, such as friction, pressure, vibration, cold, heat, or solar ...
Borlu, Murat   +2 more
core   +2 more sources

Afamelanotide for treating erythropoietic protoporphyria

open access: yes, 2017
The company submission (CS) presents evidence of the clinical and cost effectiveness of afamelanotide (SCENESSE®) for adult patients with erythropoietic protoporphyria (EPP) above the age of 18 years old compared to best supportive care. In all studies afamelanotide (16 mg) was given as a subcutaneous implant.
Lord, Joanne   +5 more
openaire   +1 more source

Design, synthesis and structural determination of antimicrobial peptides and peptidomimetics [PDF]

open access: yes
This thesis was guided by two major objectives. The first one, consisting in one global project, was the optimization and the structural determination of mixed-chirality α-helical antimicrobial peptides.
Personne, Hippolyte
core   +1 more source

Serie: Medicamenten en mondzorg. Hyperpigmentatie van de orale slijmvliezen door afamelanotide

open access: yesNederlands Tijdschrift voor Tandheelkunde, 2020
The medicament afamelanotide is an analogue of endogenous ?-melanocyte-stimulating hormone. It promotes cutaneous pigmentation, providing protection from sunlight. In dermatology, afamelanotide seems to establish therapeutic results for polymorphic light eruption, solar urticaria, erythropoietic protoporphyria, Hailey-Hailey disease, vitiligo and acne ...
de Baat, C   +5 more
openaire   +2 more sources

Melanocortin receptors in GtoPdb v.2025.3 [PDF]

open access: yes
Melanocortin receptors (provisional nomenclature as recommended by NC-IUPHAR [41]) are activated by members of the melanocortin family (α-MSH, β-MSH and γ-MSH forms; δ form is not found in mammals) and adrenocorticotrophin (ACTH ...
Caruso, Vanni   +14 more
core   +2 more sources

Home - About - Disclaimer - Privacy